GlassScriptPhysician profile
Caitlyn Risley Salley
NPI 1689346611
$2,681.27
in general payments reported to CMS, 2019-2025
29 companies · $1,675 in 2025
The $1,675 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $319 · 2024: $688 · 2025: $1,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,681.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $216.71 | 2023-2024 | Farxiga, Airsupra |
| E.R. Squibb & Sons, L.L.C. | $200.13 | 2024-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $197.68 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $171.43 | 2023-2024 | |
| Lilly USA, LLC | $163.95 | 2023-2024 | Mounjaro, Trulicity, Jardiance |
| Edwards Lifesciences Corporation | $147.70 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $143.95 | 2025 | Watchman Flx |
| Scpharmaceuticals INC. | $138.77 | 2024-2025 | |
| Abbott Laboratories | $128.09 | 2025 | Cardiomems, Jot Dx |
| Bridgebio Pharma, INC. | $124.23 | 2025 | Attruby |
| Biotronik INC. | $123.68 | 2025 | Amvia Edge |
| Novartis Pharmaceuticals Corporation | $101.79 | 2025 | |
| Alnylam Pharmaceuticals INC. | $100.44 | 2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.89 | 2024-2025 | Jardiance |
| Esperion Therapeutics, INC. | $85.26 | 2023-2025 | Nexletol, Nexlizet |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $79.93 | 2023-2025 | Repatha, Krystexxa, Otezla |
| Atricure, INC. | $51.62 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Pfizer INC. | $49.87 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.42 | 2024-2025 | Lifevest |
| Otsuka America Pharmaceutical, INC. | $39.97 | 2024 | Nuedexta |
| Cardiva Medical, INC. | $39.00 | 2025 | Savvywire |
| Exact Sciences Corporation | $38.87 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $34.15 | 2025 | |
| Cvrx, INC. | $31.98 | 2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $30.43 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Medtronic, INC. | $29.08 | 2025 | |
| Philips North America LLC | $27.07 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Ultragenyx Pharmaceutical INC. | $23.46 | 2023 | |
| Astellas Pharma US INC | $21.72 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlyn Salley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.